Synthetic Biology
News articles and reporting on synthetic biology.
The Newcastle-on-Tyne-based firm was recently awarded a trio of grants in the UK to further develop its technology and raised £2 million in a seed round.
Ginkgo Bioworks Q1 Revenues Drop 52 Percent as COVID-19 Testing Winds Down
The company booked $80.7 million in revenues, including $34.1 million from cell engineering and $46.6 million from its biosecurity business.
The company forecast a downturn over the second half of 2023, lowering its full-year revenue guidance to between $235 million and $238 million from a previous range of $261 million to $269 million.
Researchers at the University of Pennsylvania have created a startup to explore commercializing the technology, which could improve cell-based immunotherapies.
The Bay Area company counts Ginkgo Bioworks among its customers for synthetic DNA molecules between 1 Kb and 7 Kb long.